Top 50 Life Science Angel Investors in United States (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Sahin Boydas
Angel
|
8 | United States, Canada, Mexico | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $500k–$150M |
|
Milad Alucozai
Angel
|
5 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $113k–$60M |
|
Christopher Gibson
Angel
|
4 | United States, United Kingdom, France | Series A, Seed, Series B | Biotechnology, Health Care, Pharmaceutical | $1.5M–$55M |
|
Kevin Moore
Angel
|
4 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $300k–$4M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $500k–$57M |
|
Elad Gil
Angel
|
4 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2M–$117M |
|
Sam Altman
Angel
|
3 | United States, Canada, Ghana | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.2M–$100M |
|
Chris Gibson
Angel
|
3 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Kevin Mahaffey
Angel
|
3 | United States, Canada, Israel | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $700k–$30M |
|
Erik Peterson
Angel
|
3 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, SaaS, Mobile | $69k–$20M |
|
Darian Shirazi
Angel
|
3 | United States, Germany, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2M–$73M |
|
Jeff Hammerbacher
Angel
|
3 | United States, Germany | Seed, Series A, Angel | Artificial Intelligence, Software, Biotechnology | $330k–$25M |
|
Esther Dyson
Angel
|
3 | United States, Egypt, Canada | Seed, Series A, Angel | Health Care, Software, Artificial Intelligence | $330k–$16M |
|
Lars Fjeldsoe-Nielsen
Angel
|
2 | United States, United Kingdom, Denmark | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.8M–$125M |
|
Craig Mundie
Angel
|
2 | United States | Seed, Series B, Series C | Life Science, Chemical, Genetics | |
|
Jonathan Milner
Angel
|
2 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $505k–$56M |
|
Brian S. Cohen
Angel
|
2 | United States, Israel | Seed, Series A | Software, SaaS, Mobile | $300k–$12M |
|
Thomas Lee
Angel
|
2 | United States | Seed, Series A, Series B | Health Care, Medical, Artificial Intelligence | $3M–$40M |
|
Joshua Elkington
Angel
|
2 | United States | Seed | Biopharma, Life Science, Biotechnology | $2.6M–$2.6M |
|
Nat Turner
Angel
|
2 | United States, China, Colombia | Seed, Series A, Series B | Health Care, Software, Medical | $1.5M–$36M |
|
Mei Z.
Angel
|
2 | United States, United Kingdom, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1M–$156M |
|
Edward Lando
Angel
|
2 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $125k–$37M |
|
Katie Haun
Angel
|
2 | United States, United Kingdom | Seed, Series A | Blockchain, Financial Services, FinTech | $4.5M–$200M |
|
Zach Weinberg
Angel
|
2 | United States, Israel, Colombia | Seed, Series A, Pre-Seed | Software, Health Care, SaaS | $1.5M–$30M |
|
Ruchi Sanghvi
Angel
|
2 | United States, India, China | Seed, Series A, Series C | Software, Artificial Intelligence, Information Technology | $600k–$80M |
|
Gary Lauder
Angel
|
2 | United States, Canada | Series B, Series A, Seed | Software, Mobile, Internet | $1M–$22M |
|
John Ballantyne
Angel
|
2 | United States, Singapore | Seed, Series A, Angel | Health Care, Biotechnology, Therapeutics | $4.5M–$30M |
|
Thomas Tull
Angel
|
2 | United States | Series A, Series C, Series B | Artificial Intelligence, Software, Machine Learning | $12M–$250M |
|
Sujay Jaswa
Angel
|
2 | United States, Spain, Germany | Seed, Series B, Series A | Software, Apps, FinTech | $1.8M–$200M |
|
Patrick Collison
Angel
|
2 | United States, United Kingdom, Ireland | Series A, Seed, Series C | Software, Artificial Intelligence, Information Technology | $2.7M–$170M |
|
James Hong
Angel
|
2 | United States | Seed, Series A, Angel | E-Commerce, Mobile, Internet | $100k–$25M |
|
Ling Wong
Angel
|
2 | United States, Colombia | Seed, Series A, Series C | Health Care, Biotechnology, Medical | $4.4M–$450M |
|
CJ Reim
Angel
|
2 | United States | Series A, Seed, Series D | SaaS, Robotics, E-Commerce | $3.7M–$150M |
|
Varsha Rao
Angel
|
2 | United States, India, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Software | $400k–$46M |
|
Brad Flora
Angel
|
2 | United States, United Kingdom, Mexico | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $500k–$30M |
|
Jay Zaveri
Angel
|
2 | United States, Japan, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Artificial Intelligence | $1M–$6B |
|
Aiden Ross
Angel
|
2 | United States | Seed, Pre-Seed | Consulting, Life Science, Neuroscience | |
|
Avichal Garg
Angel
|
2 | United States, Canada, Mexico | Seed, Series A | Software, Blockchain, Internet | |
|
Daniel Schryer
Angel
|
2 | United States, India, Panama | Seed, Series B, Angel | Software, Internet, Mobile | $25k–$50M |
|
Nitesh Banta
Angel
|
2 | United States, Canada, India | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$47M |
|
Peter Harris
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Health Diagnostics | $2.4M–$5M |
|
Jeffrey Dean
Angel
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Information Technology | $450k–$60M |
|
Ankit Jain
Angel
|
2 | United States | Seed, Pre-Seed | Health Care, Medical, Hospital | $75k–$3.5M |
|
Robin Lingg
Angel
|
2 | United States | Seed | News, Life Science, Machine Learning | $1.5M–$3.5M |
|
Patrick Yang
Angel
|
2 | United States | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $2.5M–$50M |
|
Peter Gabriel
Angel
|
2 | United Kingdom, Belgium, United States | Seed, Series A | Music, Software, Artificial Intelligence | $1.3M–$22M |
|
Nimesh Kampani
Angel
|
2 | India, United States, Singapore | Seed, Series A, Pre-Seed | Machine Learning, Financial Services, Artificial Intelligence | $182k–$25M |
|
Alec Nielsen
Angel
|
2 | United States, Germany | Seed, Pre-Seed | Biotechnology, Biopharma, Medical | $3M–$16M |
|
David R. Walt
Angel
|
2 | United States | Seed, Series A, Series B | Biotechnology, Genetics, Life Science | $2M–$37M |
|
Michael Chambers
Angel
|
2 | United States | Series A, Venture - Series Unknown | Biotechnology, Genetics, Life Science | $30M–$55M |
| Access all 506 angel investors in United States Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Sahin Boydas is the Founder & CEO of Lovie.co. He is part of PEF Community as PEF Chapter Lead.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 291
- Round size: Seed $500k–$15M; Series A $8M–$36M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamb Labs — Lamb Labs is building model processing units that hardcode AI models into silicon for faster, more efficient inference.
- Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
- Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1M–$7M; Pre-Seed $113k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 28
- Round size: Seed $1.5M–$14M; Series A $10M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zanskar — Zanskar combines field geology, artificial intelligence, and computational geoscience to discover geothermal resources and develop clean, firm power.
- Play Health — Play Health is no longer available. The team behind it is now building Paceline Bio.
- Dunia Innovation — Catalysing the energy transition.
Kevin Moore has 15 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 109
- Round size: Seed $300k–$4M; Pre-Seed $800k–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Trace — AI orchestration layer for modern teams
- Augmend — Create documentation and an AI assistant from any video.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $6.8M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 268
- Round size: Seed $2M–$17M; Series A $9.5M–$55M; Series B $27M–$117M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Lumaril — Lumaril is a software company that develops an artificial intelligence platform for optimizing physical production operations. The company connects its platform to existing industrial control systems and uses operational data, audio and visual sensors, artificial intelligence, and machine learning to model facility performance in real time. Its platform determines operational adjustments and can autonomously modify set points, control logic, and coordination to improve production throughput and yield. Lumaril serves industrial facilities in manufacturing, chemicals, biologics, and oil and gas. The company applies AI-driven automation to existing industrial infrastructure without requiring replacement of established control systems. Its technology is designed to support continuous optimization of complex production environments.
- Infisical — Infisical is the all-in-one identity security platform for developers, machines, and AI agents. Manage identities, secrets, certs, and access.
- Serval — Serval is the AI-native ESM that automates employee requests, onboarding/offboarding, just-in-time access, and more.
Sam Altman is the Co-Founder and CEO of OpenAI. Sam previously served as Board Chair at Helion Energy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Ghana
Investor stats
- Total investments: 200
- Round size: Seed $1.2M–$9.3M; Series A $10M–$50M; Series B $17M–$100M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
- Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Kevin Patrick Mahaffey is the Founder of Lookout. He previously worked at DailyWireless.com as Founder. Kevin attended the University of Southern California, where he took BS, Electrical Engineering.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 160
- Round size: Seed $1.4M–$8.2M; Pre-Seed $700k–$5.6M; Series A $5.3M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Cara — Cara AI helps insurance agencies, brokerages, and wholesalers automate sales and servicing workflows, reduce manual tasks, and focus on client relationships.
- Osmo Studio — Osmo is an AI-native video editor for product launch videos and motion graphics. Turn ideas, Figma files, and footage into polished, on-brand animations, built as editable code.
- Triangle Health — Triangle brings your medical records together, reads them with you in plain language and researches your options, with a physician-reviewed analysis.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 65
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 193
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $23M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- SolveAI —
- Rowspace — You built your firm's edge. Compound it with AI.
- Harmattan AI — Building the Future of Autonomous Warfare.
Jeff Hammerbacher is based out of New York and is the Chairman and Co-Founder of Ortet. Jeff previously worked at New Mountain Capital as a Senior Advisor and Portfolio Company Board Member. Jeff Hammerbacher attended Harvard University.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: United States, Germany
Investor stats
- Total investments: 36
- Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamin — Improve your workflows with open-source data access and long-term memory. Query, trace, and govern with a lineage-native, format-agnostic lakehouse for agents and teams. With support for biological formats and registries.
- Ridge AI — Ridge builds interactive dashboards and AI data agents you can embed in your product, so customers see the value you deliver. Start a free trial.
- United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A, Angel
- Geography: United States, Egypt, Canada
Investor stats
- Total investments: 102
- Round size: Seed $350k–$3.5M; Angel $330k–$2.9M; Series A $1.5M–$16M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day. Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful. Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee). Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs. Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike. A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Denmark
Investor stats
- Total investments: 103
- Round size: Seed $1.8M–$10M; Series A $6.4M–$48M; Series B $15M–$125M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Blue — An Operating System for your Personal Health. Join the waitlist here.
- UrbanKisaan — Smart growing rooms and AI that reads plant DNA. Breed and grow crops faster, all year, in any climate.
- Colossal Biosciences — The science of genetics. The business of discovery.
Craig J. Mundie is based out of Seattle, Washington, and is the Owner of Mundie & Associates LLC. Craig previously worked at Microsoft as a Chief Research and Strategy Officer. Craig J. Mundie attended the Georgia Institute of Technology.
Show more...Investment focus
- Industry: Life Science, Chemical, Genetics
- Stage:Seed, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stoicheia — NAGASPIN99 adalah link situs slot gacor hari ini yang menawarkan bonus berlimpah khusus pemain baru. Klik Daftar dan raih kemenangan besar bersama naga api sekarang juga.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $505k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBM Corporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses. Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community. Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally. Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model. Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 48
- Round size: Seed $300k–$3M; Series A $1.2M–$12M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — Discover and compare the best classes and courses in NYC, LA, Chicago, Nashville, Houston, Boston & DC. Read reviews, book online, & earn discounts on every class. It's free!
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Tom X Lee is the CEO of Galileo. Took up BS, Biology at Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 19
- Round size: Seed $3M–$9.5M; Series A $10M–$22M; Series B $26M–$40M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Allara — Allara is your all-in-one virtual care team for hormonal, metabolic & gynecological conditions such as PCOS and Endometriosis.
- Systole Health — Join Systole Health and take control of your heart health. Our personalized group virtual care combines expert-led medical treatment with the power of community support.
- Parakeet Health — Parakeet converts patient demand into revenue: verified lift above your own baseline across scheduling, recall, referrals, and no-show recovery. Pay for performance.
Joshua Elkington
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.6M–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, China, Colombia
Investor stats
- Total investments: 80
- Round size: Seed $1.5M–$6.3M; Series A $3M–$25M; Series B $5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Collectors — The infrastructure that powers trust, security, and opportunity in collectibles.
- Iterative Health — Iterative Health empowers its network of clinical research sites and sponsors to accelerate the development and delivery of novel therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 32
- Round size: Seed $4M–$101M; Pre-Seed $1M–$11M; Series A $17M–$156M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FlyMy.AI — Real-time AI cloud
- Medra AI — Building robotics to accelerate scientific breakthroughs. At Medra, our mission is to automate repetitive wetlab tasks so scientists can more easily collect data and run the experiments needed to make groundbreaking scientific discoveries.
- Periodic Labs — From bits to atoms.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 478
- Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022.
Show more...Investment focus
- Industry: Blockchain, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United States, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $4.5M–$200M; Series A $15M–$55M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
- Coinbase Token Manager — LiquiFi helps crypto companies automate token vesting, issue token grants in compliance, and manage their token cap table.
Zach Weinberg is based out of New York, New York and is the founder & CEO of Curie.Bio. Zach previously worked at Flatiron Health as a co-founder, president & COO. Zach Weinberg attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, Colombia
Investor stats
- Total investments: 77
- Round size: Seed $1.5M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $5M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
- Crosby — Crosby is an AI-first law firm that reviews contracts in under an hour. NDAs, MSAs, and DPAs handled with expert lawyers and AI working together.
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Ruchi Sanghvi is based out of San Francisco, California, and is the Founder & General Partner of South Park Commons. Ruchi previously worked at Dropbox as a VP of Operations. Ruchi Sanghvi attended Carnegie Mellon University. Ruchi Sanghvi was awarded a TechFellow Best Engineering Leadership Award in 2011.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series C
- Geography: United States, India, China
Investor stats
- Total investments: 67
- Round size: Seed $600k–$4.6M; Series A $3M–$23M; Series C $18M–$80M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Sundial — Stop writing pipelines and complex SQL. Go from raw data to entities, metrics, visualizations and answers in just a few clicks
- SCUBA Analytics — Unlock the power of data collaboration in experience-driven industries. Gain intelligence, measurement, and activation of audience opportunities with SCUBA's privacy-enabled insights.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Gary Lauder is the Founder & Managing Director of Lauder Partners LLC, a Silicon Valley-based venture capital firm investing primarily in information technologies. He has been a venture capitalist since 1985, investing in over 80 private companies. He is also Chairman of ActiveVideo Networks. Other directorships: OnLive, net2tv, Promptu, MediaFriends and ShotSpotter. Investments are primarily in television/IPTV technology and WWW arenas. In the 1980's, he worked at the venture firms of Aetna, Jacobs & Ramo Technology Ventures, as well as Wolfensohn Associates. He holds a BA in International Relations from the University of Pennsylvania; a BS in Economics from the Wharton School; and an MBA from the Stanford Graduate School of Business. He is the co-creator of the Aspen Institute's Socrates Society with Laura, his wife. He is a member of the inaugural class of the Aspen Institute's Henry Crown Fellowship Program. He has had a working cable modem (usually) in his home since 1994. He is co-inventor of 12 patents, has spoken at over 100 industry forums, and, since 1992, has published several articles about the future of the cable industry...that he still stands by.
Show more...Investment focus
- Industry: Software, Mobile, Internet
- Stage:Series B, Series A, Seed
- Geography: United States, Canada
Investor stats
- Total investments: 14
- Round size: Series A $1M–$22M; Series B $9.4M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnyRoad — Brands use AnyRoad to manage, measure and scale their, live, virtual, and hybrid experiences and events with live data and unique insights
- Stella — Stella is an industry consortium of large frontline and hourly employers who share non-hired and laid-off applicants with one another through the Stella marketplace. Using Stella's iOS, Android mobile apps and our map-based interface, job seekers can easily explore nearby network job openings. Applying is a snap thanks to our common jobapplication and tight employer ATS integrations. Applicants do not have to fill out the same information over and over again. This streamlined process improves the candidate experience by saving time and effort.Stella has raised $25M+ from world class investors. Dozens of America’s largest employers are already using Stella to hire talent and to help their laid-off employees find new work more quickly. More companies and jobs are being added every day. Our growing team is based in New York City and Sydney, Australia.Stella. Finding work has never been easier. Discover more at https://stella.jobs
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Angel
- Geography: United States, Singapore
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- SmartWorx — AI-native platform for regulated, high-stakes environments. Purpose-built to solve the hardest integration and workflow problems where compliance isn't optional.
- GlucoTrack — We are pleased to announce that the diabetes technology business focused on developing our Continuous Blood Glucose Monitor (CBGM) platform will now operate
Thomas Tull is the founder, chairman, and chief executive officer of Legendary Entertainment, a media company that produces content for mainstream audiences.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Series C, Series B
- Geography: United States
Investor stats
- Total investments: 45
- Round size: Series A $12M–$60M; Series B $40M–$163M; Series C $40M–$250M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Slate Auto — 205 miles of range. Converts from pickup to SUV. Wraps instead of paint. Starting at $24,950.
- Re:Build — Re:Build Manufacturing helps organizations move from concept to full-scale production by uniting design, engineering, and manufacturing to bring innovative products to market.
- Colossal Biosciences — The science of genetics. The business of discovery.
Sujay Jaswa is based out of [LOCATION - City, State] and is the Co founder and Managing Partner of WndrCo. Sujay previously worked at Dropbox as a Business Founder, CFO & VP of Business. Sujay Jaswa attended the Harvard Business School.
Show more...Investment focus
- Industry: Software, Apps, FinTech
- Stage:Seed, Series B, Series A
- Geography: United States, Spain, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
- point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
- PlayerZero — PlayerZero builds an engineering world model so SRE, QA, and support teams resolve incidents, prevent defects, and close tickets faster.
Patrick Collison is a CEO of Stripe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series C
- Geography: United States, United Kingdom, Ireland
Investor stats
- Total investments: 72
- Round size: Seed $2.7M–$13M; Series A $10M–$105M; Series C $20M–$170M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
- The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
- SendCutSend — SendCutSend is an online custom manufacturing service specializing in rapid, high-precision sheet metal fabrication and CNC machining. Customers simply upload their digital design files to get professional-grade parts manufactured and shipped to their door, with turnaround times as fast as 24 hours.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!James Hong
Show more...Investment focus
- Industry: E-Commerce, Mobile, Internet
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 29
- Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for the betterment of humanity today, and in the future. Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong. Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries. As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC). Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series C
- Geography: United States, Colombia
Investor stats
- Total investments: 45
- Round size: Seed $4.4M–$19M; Series A $8.1M–$36M; Series C $50M–$450M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
- Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
- Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more...Investment focus
- Industry: SaaS, Robotics, E-Commerce
- Stage:Series A, Seed, Series D
- Geography: United States
Investor stats
- Total investments: 18
- Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Varsha Rao is an Executive Partner at Flare Capital Partners, former Head of Global Operations at Airbnb, CEO of Nurx and COO at Clover Health. She was the Co-Founder of Eve.com. Rao received her BS/BA in Economics/Math from the University of Pennsylvania and an MBA from Harvard Business School. She is an active angel investors with successful investments in AI-Infra, Healthcare, Vertical AI, Consumer Tech and more.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, India, France
Investor stats
- Total investments: 64
- Round size: Seed $2M–$15M; Pre-Seed $400k–$3M; Series A $5M–$46M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Alex AI — Alex is the AI recruiter that puts sourcing, screening, and scheduling on autopilot. Fast-track vetting so you interview the best in days.
- TextQL — TextQL is you personal virtual data analyst, built for enterprise and powered by AI. Ask in natural english and Ana can build insightful analysis, stunning charts, and powerful models, all with enterprise-grade security.
- Raindrop — Trace every run. Auto-fix silent failures. Simulate before shipping.
Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, United Kingdom, Mexico
Investor stats
- Total investments: 236
- Round size: Seed $500k–$5M; Pre-Seed $500k–$500k; Series A $1M–$30M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
- Truewind — Using AI to power bookkeeping & finance means less errors, more transparency, and faster monthly close
- Ellipsis — Ellipsist is a virtual teammate that turns every engineer into a 10x engineer. After installing into the GitHub repository, developers assign work to the bot, such as creating pull requests, conducting code reviews, and addressing peer feedback.
Jay Zaveri is based out of Palo Alto, California and is the Founder & Partner of Natural Capital. Jay previously worked at Groq as a Board Director. Jay Zaveri attended the NALSAR. Jay Zaveri has received 18 awards for his work in cartoons and new media technology, including the Best Animated Short award at the Hollywood Film Festival.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 72
- Round size: Seed $1M–$4M; Series A $3M–$25M; Series B $25M–$6B
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
- Litterati — Litterati is an app that encourages users to pick up and track litter.The app plans to let users join groups, so that schools, clubs, and other communities can track their collective efforts rather than having to go solo. It will also introduce maps, so litter-pickers can see what else is being picked up in their neighborhoods.
- Kingdom — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Aiden Ross
Show more...Investment focus
- Industry: Consulting, Life Science, Neuroscience
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Spike Neuro — We seek to provide equitable access to development resources so all researchers have the opportunity to impact the neuroscience community.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Industry: Software, Blockchain, Internet
- Stage:Seed, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Dan Schryer was formerly CEO of DCI Data Centers, a Blackstone backed technology real estate company. Together with Guru Gowrappan, formerly CEO of Verizon Media, he co-founded Bali Venture Partners, LLC to invest in seed and growth stage debt and equity opportunities.
Show more...Investment focus
- Industry: Software, Internet, Mobile
- Stage:Seed, Series B, Angel
- Geography: United States, India, Panama
Investor stats
- Total investments: 37
- Round size: Seed $25k–$2M; Angel $75k–$670k; Series B $150k–$50M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- 54gene — 54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
- Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
- SOS Hydration — Rescue yourself from dehydration with SOS, doctor formulated rapid hydration with 80x less sugar than sports drinks and only 3g carbs and 10 calories.
Nitesh Banta is the Co-Founder & CEO at B12.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 117
- Round size: Seed $1.3M–$16M; Pre-Seed $500k–$2.5M; Series A $6.5M–$47M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Pelgo — Pelgo re-engineers outplacement and severance for the modern enterprise. Intelligent severance administration, next-gen outplacement, and severance maximization in one platform.
- howie — Howie is an AI calendar secretary for email, SMS, iMessage, Gmail, and Google Calendar. He books meetings, protects focus time, follows up, and handles reminders.
- Self Protocol — Future-proof your organization with identity and agent infrastructure already accessible to billions of people across 180+ countries and trusted by companies like Google.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Peter Harris
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.4M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Jeff Dean is the Co-founder and CEO of DiscoveryLoop. He previously worked at Google as Chief Scientist at Google DeepMind and Google Research. Jeff attended the University of Washington, where he earned a PhD in Computer Science.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 112
- Round size: Seed $2.5M–$34M; Pre-Seed $450k–$3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
- Phinity Labs — Phinity Labs builds AI systems designed to fully automate the entire silicon microchip engineering process, spanning from original architectural concepts to final manufacturing preparation.
- Volantis — Volantis specializes in developing AI-driven semiconductor solutions. The company focuses on creating advanced systems that support high-performance computing for various applications, including networking, data centers, and edge computing. Volantis provides integrated hardware and software platforms designed to optimize processing power, energyefficiency, and scalability. Their technology aims to enhance the capabilities of existing infrastructure, making it adaptable to emerging computational demands. The company's solutions cater to industries that require robust, efficient computing power at scale.
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Round size: Seed $75k–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Robin Lingg - Chairman of the Board of Directors @ DeinDeal
Show more...Investment focus
- Industry: News, Life Science, Machine Learning
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $1.5M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AppliedXL — Applied XL is an information company that uses machine learning and editorial algorithms to anticipate disruptions to the health of people, places and planet.
Patrick Z. Yang is based out of San Francisco, California, and is the Co-Founder & General Partner of Amity Ventures. Patrick previously worked at Highland Capital Partners as a Vice President. Patrick Z. Yang attended the University of California Berkeley.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 34
- Round size: Seed $2.5M–$7.6M; Series A $5M–$16M; Series B $35M–$50M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Peter is clearly way more than a global music legend. He divides his time and energy between his music, humanitarian projects, business investments and his family.He became an investor and advisor to The Filter in 2006 and brings with him a clear vision of a need for smart filters to help us make sense of a world with too many choices. Workingwith Peter is inspiring – his passion and creativity help drive and motivate the team.
Show more...Investment focus
- Industry: Music, Software, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United Kingdom, Belgium, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.3M–$3.5M; Series A $5M–$22M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Tumelo — Tumelo is an impact-focused financial technology firm. Our mission is to enable retail investors and pension members to create and benefit from a more sustainable investment system. We do this by partnering with investment and pension providers, enabling them to provide their customers with transparency over the companies they own and ashareholder voice on issues they care about, such as gender equality or climate change. Our solution is white-label software delivered via APIs and/or a user dashboard. Our software integrates with existing investment platforms improving customer engagement, acquisition and retention for providers.
- Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Nimesh is the Founding Partner at 108 Capital, a Growth-stage venture fund partnering with founders building digital-first, scalable and sustainable businesses. Prior, Nimesh was the cofounder at trica, a full-stack technology platform for growth-stage investments and equity management. He has been an avid Investor in private markets and is alsofounding venture partner for India’s first $100Mn revenue based financing fund N+1 Capital and also advisor & Board member of Campus Fund – 1st dorm fund in India
Show more...Investment focus
- Industry: Machine Learning, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: India, United States, Singapore
Investor stats
- Total investments: 56
- Round size: Seed $182k–$4.6M; Pre-Seed $400k–$2M; Series A $3.1M–$25M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- KhiladiPro — AI that visualises intent as motion. Cricket coaching, badminton coaching, AI swing analysis, KAI fitness exam, smart courts.
- Koinbasket — KoinBasket lets you invest in diversified cryptocurrency portfolios and indexes with Bitcoin, Ethereum, Altcoins and DeFi tokens on Binance, Coinbase and Huobi.
- Intents Mobi — Mobile analytics, Logistics, Transportation, Fleet Management, Data Analytics
Alec Nielsen is the Founder & CEO at Asimov.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Germany
Investor stats
- Total investments: 6
- Round size: Seed $3M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
- Lamin — Improve your workflows with open-source data access and long-term memory. Query, trace, and govern with a lineage-native, format-agnostic lakehouse for agents and teams. With support for biological formats and registries.
- General Proximity — General Proximity pioneers next-generation medicines by controlling biological processes through proximity. Redefining the future of medicine for all humankind.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 8
- Round size: Seed $2M–$5M; Series A $18M–$25M; Series B $5.4M–$37M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Vizgen — Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The highthroughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.
- Stoicheia — NAGASPIN99 adalah link situs slot gacor hari ini yang menawarkan bonus berlimpah khusus pemain baru. Klik Daftar dan raih kemenangan besar bersama naga api sekarang juga.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Series A, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 3
- Round size: Series A $30M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — A comprehensive platform and product suite for advanced therapeutics.
Life Science Angel investor funding in United States at a glance
Stats across 329 deals from 506 investors.
Access all 506 angel investors in United States Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 506 angel investors investing in United States Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!